2nd Faculty of Medicine, Department of Paediatric Neurology, Charles University and Motol University Hospital, Prague, Czech Republic.
2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Brain Pathol. 2019 Jul;29(4):473-484. doi: 10.1111/bpa.12686. Epub 2019 Jan 27.
Malformations of cortical development (MCD) comprise a broad spectrum of developmental brain abnormalities. Patients presenting with MCDs often suffer from drug-resistant focal epilepsy, and some become candidates for epilepsy surgery. Their likelihood of achieving freedom from seizures, however, remains uncertain, and depends in a major part on the underlying pathology. Tissue samples obtained in epilepsy surgery form the basis of definite histopathological diagnosis; however, new molecular genetic methods have not yet been implemented in diagnostic processes for MCD cases. Furthermore, it has not been completely understood how the underlying pathology affects patients' outcomes after epilepsy surgery. We performed a systematic literature review of studies describing both histopathological and molecular genetic findings in MCD, along with studies on epilepsy surgery outcomes. We aimed to correlate the genetic causes with the underlying morphological abnormalities in focal cortical malformations and to stress the importance of the underlying biology for patient management and counseling. From the summarized findings of multiple authors, it is obvious that MCD may have a diverse genetic background despite a similar or even identical histopathological picture. Even though most of their molecular genetic findings converge on various levels of the PI3K/AKT/mTOR pathway, the exact mechanisms underlying MCD formation have not yet been completely described or indeed how this pathway generates a diverse range of histological abnormalities. Based on our findings, we therefore propose that all patients diagnosed and operated for drug-resistant epilepsy should have an integrated molecular and pathological diagnosis similar to the current practice in brain tumor diagnostic processes that might lead to more accurate diagnosis and effective stratification of patients undergoing epilepsy surgery.
皮质发育障碍(MCD)包括广泛的发育性脑异常。患有 MCD 的患者常患有耐药性局灶性癫痫,有些则成为癫痫手术的候选者。然而,他们摆脱癫痫发作的可能性仍然不确定,这在很大程度上取决于潜在的病理。癫痫手术中获得的组织样本是明确的组织病理学诊断的基础;然而,新的分子遗传方法尚未在 MCD 病例的诊断过程中实施。此外,尚未完全了解潜在的病理如何影响癫痫手术后患者的结果。我们对描述 MCD 中组织病理学和分子遗传学发现以及癫痫手术结果的研究进行了系统的文献回顾。我们旨在将遗传原因与局灶性皮质发育不良中的潜在形态学异常相关联,并强调潜在生物学对患者管理和咨询的重要性。从多位作者的总结发现中可以明显看出,尽管组织病理学图片相似甚至相同,但 MCD 可能具有多种遗传背景。尽管他们的大多数分子遗传学发现都集中在 PI3K/AKT/mTOR 通路的各个水平上,但 MCD 形成的确切机制尚未完全描述,或者该途径如何产生多种组织学异常。基于我们的发现,因此我们建议,所有被诊断为耐药性癫痫并接受手术的患者都应进行分子和病理综合诊断,类似于目前在脑肿瘤诊断过程中的实践,这可能会导致更准确的诊断和对接受癫痫手术的患者进行有效的分层。